Home » Newsletters » BioWorld Asia

BioWorld Asia

May 30, 2001

View Archived Issues

Neurotech Raises $30M Privately To Fund Work In Cell Therapies

Small RNA Chunks Can Silence Single Genes In Mammalian Cells

Biota Purchases U.S. Company With Antivirals Program For $8M

Nine German Proteome Projects Get Started Under New Program

UK Initiative Provides Hospitals Incentive For Research Spin-Offs

EU Members Falling Behind On Biotechnology Research Rules

Hybrigenics, Institut Curie Create Joint Cancer Research Facility

Transgene Financing Nets $54M; BioMérieux Stake Reaches 70%

Ceros Settles In UK To Work On Leptin, Bone Formation Link

Other News To Note

TVMs First Closing Of New Venture Fund Nets EUR70M

MS Drugs Spur 33 Percent Growth In Israeli Biotech

EMEA Establishes New Rules Covering Gene Transfer Testing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...